Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
709
datasets available to search
ShareScore release 0.9.0
Dataset results
709 results for “mood”
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
ClinicalTrials.gov study NCT00704379. IPD Sharing: Not stated. Countries: 1. Publications: 29.
Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
ClinicalTrials.gov study NCT00280566. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder
ClinicalTrials.gov study NCT00552760. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Research Aimed at Improving Both Mood and Weight
ClinicalTrials.gov study NCT02246413. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Group-Based Behavioral Therapy Combined With Stimulant Medication for Treating Children With Attention Deficit Hyperactivity Disorder and Impaired Mood
ClinicalTrials.gov study NCT00632619. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pioglitazone in Patients With Mood Disorders
ClinicalTrials.gov study NCT01559857. IPD Sharing: NO. Countries: 1. Publications: 1.
Impact of Hot Flashes on Sleep and Mood Disturbance
ClinicalTrials.gov study NCT01116401. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Brief structured respiration practices enhance mood and reduce physiological arousal
Open the record for dataset details and reuse information.
Negative mood affects the expression of negative but not positive emotions in mice
<p><span><span><span><span><span><span><span><span><span><span><span>Whether, and to what extent animals experience emotions is crucial for understanding their decisions and behaviour, and underpins a range of scientific fields, including animal behaviour, neuroscience, evolutionary biology and animal welfare science. However, research has predominantly focussed on alleviating negative emotions in animals, with the expression of positive emotions left largely unexplored. Therefore, little is known about positive emotions in animals and how their expression is mediated. We used tail handling to induce negative mood in laboratory mice and found that whilst being more anxious and depressed increased their expression of a discrete negative emotion ('disappointment') meaning that they were less resilient to negative events, their capacity to express a discrete positive emotion ('elation') was unaffected relative to control mice. Therefore, we show not only that mice have discrete positive emotions, but that they do so regardless of their current mood state. Our findings are the first to suggest that the expression of discrete positive and negative emotions in animals are not equally affected by long-term mood state. Our results also demonstrate that repeated negative events can have a cumulative effect to reduce resilience in laboratory animals, which has significant implications for animal welfare.</span></span></span></span></span></span></span></span></span></span></span></p>
H-2020 MOOD Scoping review of Tularemia on the human, animal, vector and environmental covariates
<div> <p><span><span>The dataset </span><span>contains</span><span> quantitative data on the human, animal</span><span>, </span><span>vector</span><span> and environmental covariates associated with </span><span>Tularemia</span><span> retrieved from scientific papers through a standardized search on PubMed, Embase, Web of Science, and Scopus. Inclusion criteria were data on the association between disease and covariates, language (English or other EU languages), </span><span>time frame</span><span> (30 years), geographical location (Europe), and publication type. Studies without data or with non-original or duplicated data (reviews, editorials, letters, model</span><span>l</span><span>ing studies with no data), lacking denominators or reference populations, unavailable </span><span>full-texts</span><span>, referring to data older than 2000 or gathered outside Europe, were excluded. The final </span><span>time frame</span><span> covered a period from 2000 to 2022.</span></span><span> </span></p> </div> <div> <p><span><span>The important </span><span>human, animal</span><span>, </span><span>vector</span><span> and environmental</span><span> covariates were extracted with the associated quantitative information, and the related information on the diseases. </span><span>The covariates were </span><span>submitted</span><span> to a revision process </span><span>and </span><span>label</span><span>led</span><span> according to a </span><span>labelling</span><span> system</span><span> agreed upon among a group of experts within the MOOD (grant agreement No 874850; </span></span><a href="https://mood-h2020.eu/" target="_blank" rel="noreferrer noopener"><span><span>https://mood-h2020.eu/</span></span></a><span><span>) project consortium.</span></span><span> </span></p> </div>
H-2020 MOOD Scoping review of Leptospirosis, Influenza A and Chikungunya on the human, animal, vector and environmental covariates
<div> <p><span><span>The dataset </span><span>contains</span><span> quantitative data on the </span><span>human, animal</span><span>, </span><span>vector</span><span> and </span><span>environmental covariates associated with influenza A, Chikungunya, and Leptospirosis retrieved from scientific papers through a standardized search on PubMed, Embase, Web of Science, and Scopus. Inclusion criteria were data on the association between disease and covariates, language (English or other EU languages), </span><span>time frame</span><span> (30 years), geographical location (Europe), and publication type. </span><span>Studies without data or with non-original or duplicated data (reviews, editorials, letters, </span><span>modelling</span><span> studies with no data), lacking denominators or reference populations, unavailable </span><span>full-texts</span><span>, referring to data older than 2000 or gathered outside Europe, were excluded.</span><span> The final </span><span>time frame</span><span> covered a period from 2000 to 2022.</span></span><span> </span></p> </div> <div> <p><span><span>The important </span><span>human, animal</span><span>, </span><span>vector</span><span> and environmental</span><span> covariates were extracted with the associated quantitative information, and the related information on the diseases. The covariates were </span><span>submitted</span><span> to a revision process </span><span>and </span><span>label</span><span>led</span><span> according to a </span><span>labelling</span> <span>system agreed upon among a group of experts within the MOOD (grant agreement No 874850; </span></span><a href="https://mood-h2020.eu/" target="_blank" rel="noreferrer noopener"><span><span>https://mood-h2020.eu/</span></span></a><span><span>) project consortium.</span></span><span> </span></p> </div>
Data from: Mapping movement, mood, motivation, and mentation in the subthalamic nucleus
The anatomical connections of the subthalamic nucleus (STN) have driven hypotheses about its functional anatomy, including the hypothesis that the precise anatomical location of STN deep brain stimulation (DBS) contributes to the variability of motor and non-motor responses across Parkinson disease (PD) patients. We previously tested that hypothesis using a three-dimensional (3D) statistical method to interpret the acute effects of unilateral DBS at each patient's clinically optimized DBS settings and active contact. Here we report a similar analysis from a new study in which DBS parameters were standardized and DBS locations were chosen blind to clinical response. In 74 individuals with PD and STN DBS, STN contacts were selected near the dorsal and ventral border of the STN contralateral to the more affected side of the body. Participants were tested off PD medications in each of 3 unilateral DBS conditions (ventral STN DBS, dorsal STN DBS and DBS off) for acute effects on mood, apathy, working memory, response inhibition and motor function. Voltage, frequency, and pulse width were standardized, and participants and raters were blind to condition. In a categorical analysis, both dorsal and ventral STN DBS improved mean motor function without affecting cognitive measures. Ventral STN DBS induced greater improvement in rigidity and anxiety than dorsal STN DBS. In the 3D analysis, contact location was significant for body hypokinesia, rigidity, and resting tremor, with the greatest improvement occurring with DBS in dorsal STN and zona incerta. The 3D results provide new, direct functional evidence for the anatomically-derived model of STN, in which motor function is best represented in dorsal STN. However, our data suggest that functional segregation between motor and non-motor areas of the STN is limited, since locations that induced improvements in motor function and mood overlapped substantially.
Assessment of insight in hospitalized neurological patient: Cognitive profile and mood disorder
<p>Purpose:Many studies have evaluated the characteristics of insight, especially in psychiatric patient pop-ulations. However, this construct has been poorly examined within neurological disorders. We exploredthe relationship between altered insight, mood disorders and neurocognitive functioning in a sample ofpatients admitted to a neurological rehabilitation unit.Method:Each patient, at the time of hospitalization (T0), underwent an evaluation of the overall cogni-tive profile, of the frontal functions, and the compilation of scales aimed at investigating the 4 domainsunder examination of insight and anxiety-depressive symptomatology. After 3 months (T1), at the end ofthe rehabilitative and supportive treatment, the patients underwent the same evaluation performed atT0.Results:Our results showed significant differences between T0 and T1 in the variables examined relatedto insight. In particular, there was a correlation between the global cognitive profile, including executivefunctions, and all insight domains. This confirms how the degree of cognitive deficit, especially of exec-utive type, affects all levels of awareness of the individual.We have also found correlations between mood disorders and insight. In particular, our results showthat depression versus anxiety plays a fundamental role in a person’s awareness.Conclusions:The study of insight is fundamental not only for the relapses it could have on the patient, butalso on those to health care professionals. In fact, having an adequate insight could lead to a greater moti-vation of the patient to be more complimentary to pharmacological and rehabilitative therapies, alsofavoring social reintegration.</p>
Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression
ClinicalTrials.gov study NCT00487500. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood Disorders
ClinicalTrials.gov study NCT02860910. IPD Sharing: NO. Countries: 1. Publications: 2.
Mood Tracker Smartphone App for Management of Emotional Distress After TBI
ClinicalTrials.gov study NCT04410770. IPD Sharing: YES. Countries: 1. Publications: 1.
The Effect of Nurse Practitioner (NP-led) Care Upon Mood in People With Multiple Sclerosis
ClinicalTrials.gov study NCT04388592. IPD Sharing: NO. Countries: 1. Publications: 29.
Effect of Omega-3 Fatty Acids on Kynurenine Metabolism and Mood
ClinicalTrials.gov study NCT05520437. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Probiotic Administration on Mood
ClinicalTrials.gov study NCT05343533. IPD Sharing: NO. Countries: 1. Publications: 2.
Emotion, Mood and Executive Function in Parkinson's Disease (PD)
ClinicalTrials.gov study NCT01385735. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.